Drug Trial Radar · NCT05072314
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,300
Planned (sponsor's estimate)
Start
Jul 27, 2022
Primary completion
May 2028
Study completion May 2029
Sponsor
- Lead sponsor
- Monash UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Royal Perth Hospital
- First posted
- Oct 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre, prospective, randomised, double blind, placebo-controlled, parallel assessment, safety and effectiveness superiority study.
Conditions
- Breast Cancer
- Breast Cancer Female
- Breast Conserving Surgery
- Mastectomy
Interventions
lidocaine 2% and 10%Drug
Lidocaine infusion: 1. Commencing with an intravenous bolus after induction of anaesthesia, 0.125 ml/kg of lean body weight (LBW) of 2% lidocaine (2.5 mg/kg).\* 2. Followed by a 2% lidocaine intravenous infusion for the duration of surgery, 0.1665 ml/kg/h of LBW (3.33 mg/kg/hr).\* 3. A post-operative subcutaneous 0.0222 ml/kg/hr of LBW 10% lidocaine infusion for up to 24 hours thereafter (2.22 mg/kg/hr). Dosage will be capped at a maximum lean body weight of 68kg. * \*Day-case surgery receives intraoperative bolus and intraoperative infusion only
PlaceboDrug
Placebo infusion: 1. Commencing with an intravenous bolus after induction of anaesthesia, 0.125 ml/kg of lean body weight (LBW) of 0.9% Saline solution.\* 2. Followed by a 0.9% Saline solution intravenous infusion for the duration of surgery, 0.1665 ml/kg/h of LBW (3.33 mg/kg/hr).\* 3. A post-operative subcutaneous 0.0222 ml/kg/hr of LBW 0.9% Saline solution infusion for up to 24 hours thereafter (2.22 mg/kg/hr). Dosage will be capped at a maximum lean body weight of 68kg. * \*Day-case surgery receives intraoperative bolus and intraoperative infusion only
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of moderate or severe CPSP at 1 year after surgery, as reported by the patient at the follow-up review.Time frame: 1 year post-surgery
Locations
49 sites in 4 countries. Site status is shown where the registry gives one.
Nepean Hospital
Kingswood, New South Wales, Australia · Recruiting
Blacktown Mount Druitt Hospital
Mount Druitt, New South Wales, Australia · Recruiting
Royal North Shore Hospital
Sydney, New South Wales, Australia · Recruiting
Westmead Hospital
Sydney, New South Wales, Australia · Completed
St George Hospital
Sydney, New South Wales, Australia · Recruiting
Royal Brisbane and Women's Hospital
Brisbane, Queensland, Australia · Completed
Queen Elizabeth II Jubilee Hospital
Coopers Plains, Queensland, Australia · Active not recruiting
Mackay Base Hospital
Mackay, Queensland, Australia · Active not recruiting
Rockhampton Hospital
Rockhampton, Queensland, Australia · Completed
Gold Coast Hospital and Health Service- Gold Coast University Hospital
Southport, Queensland, Australia · Completed
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia · Recruiting
Flinders Medical Centre
Bedford Park, South Australia, Australia · Recruiting
Royal Hobart Hospital
Hobart, Tasmania, Australia · Recruiting
Anaesthetic Group Ballarat
Ballarat, Victoria, Australia · Completed
Ballarat Health Services (Grampians Health)
Ballarat, Victoria, Australia · Active not recruiting
Barwon Health - University Hospital Geelong
Geelong, Victoria, Australia · Recruiting
The Alfred
Melbourne, Victoria, Australia · Recruiting
Royal Melbourne Hospital
Melbourne, Victoria, Australia · Active not recruiting
St Vincent's Hospital Melbourne
Melbourne, Victoria, Australia · Recruiting
Northern Hospital
Melbourne, Victoria, Australia · Withdrawn
Monash Health - Moorabbin Hospital
Melbourne, Victoria, Australia · Completed
Maroondah Hospital - Eastern Health
Ringwood East, Victoria, Australia · Recruiting
Goulburn Valley Health
Shepparton, Victoria, Australia · Completed
Latrobe Regional Hospital
Traralgon, Victoria, Australia · Withdrawn
Bentley Health Service
Bentley, Western Australia, Australia · Recruiting
Royal Perth Hospital
Perth, Western Australia, Australia · Recruiting
St John of God Subiaco
Perth, Western Australia, Australia · Recruiting
Pamela Youde Nethersole Eastern Hospital
Chai Wan, Hong Kong · Recruiting
Ruttonjee Hospital
Wan Chai, Hong Kong · Recruiting
North District Hospital
Shatin, Sha Tin, Hong Kong · Recruiting
Auckland City Hospital
Auckland, Auckland, New Zealand · Recruiting
Middlemore Hospital
Auckland, Middlemore, New Zealand · Recruiting
Waikato Hospital
Hamilton, Waikato Region, New Zealand · Recruiting
Belfast City Hospital
Belfast, United Kingdom · Recruiting
Southmead Hospital, North Bristol Trust
Bristol, United Kingdom · Recruiting
Darlington Memorial Hospital
Darlington, United Kingdom · Terminated
Russells Hall Hospital
Dudley, United Kingdom · Recruiting
Royal Liverpool and Broadgreen Hospitals
Liverpool, United Kingdom · Recruiting
Whittington Hospital
London, United Kingdom · Recruiting
Royal Marsden Hospital - London and Sutton
London, United Kingdom · Recruiting
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.